Target Price Playground
GSK
$47.76
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on GSK? Launch with your exact active legs & +-12.0% target.
Forward Projection
If price hits $42 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Moderately bearish. Debit, capped max profit + loss.
๐ฏ Target
1-Click Institutional Target Anchors:
56d from today
โ๏ธ Legs
LONG PUT ยท $48 ยท Jan '27
Qty 1 ยท Premium $2.19 ยท ฮ -0.47
SHORT PUT ยท $44 ยท Jan '27
Qty 1 ยท Premium $0.7 ยท ฮ -0.21
P&L at Expiry
Stock (100 sh)
Bear Put Spread
Now
Target
๐ก Stock vs Options at Target
If GSK hits $42 by Jan 15: the bear put spread returns +$250 (167.5%) on $150 risked, vs $-573 (-12.0%) for 100 shares on $4,776. Options give 14.0ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (56 days out). P&L shown is the value at expiry if GSK is at $42.
๐ Projected Return
P&L if GSK hits $42 by Jan 15
+$250
+167.5% on $150 risked
Max Profit
+$250
If the stock โค $44 at expiry
Max Loss
โ$150
Net debit
Break-even
$46.50
-2.63% from spot
Prob. of Profit at Expiry (PoP)
41.0%
Below breakeven ($46.50)
ยท Touch Target: 31%
30-Day Theta Burn (If Flat)
โ$12
8.0% of entry cost ยท Daily ฮ: $-0.39/day
Net ฮ / ฮ / V
-26.27 / -0.39 / 2.09
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| GSK Price | Today | +3d (Nov 23) | +7d (Nov 27) | Dec 8 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $38 (-20%) | +$223 | +$226 | +$228 | +$236 | +$248 | +$251 |
| $41 (-15%) | +$188 | +$191 | +$195 | +$206 | +$232 | +$251 |
| $42 (-12%) โ target | +$157 | +$160 | +$164 | +$175 | +$206 | +$251 |
| $43 (-10%) | +$134 | +$136 | +$139 | +$149 | +$179 | +$251 |
| $45 (-5%) | +$67 | +$67 | +$68 | +$71 | +$79 | +$114 |
| $47 (-2%) | +$26 | +$25 | +$25 | +$22 | +$12 | -$29 |
| $48 (0%) โ spot | -$0 | -$1 | -$3 | -$9 | -$29 | -$125 |
| $49 (+2%) | -$24 | -$26 | -$28 | -$37 | -$64 | -$149 |
| $50 (+5%) | -$56 | -$58 | -$61 | -$72 | -$102 | -$149 |
| $53 (+10%) | -$96 | -$99 | -$102 | -$113 | -$136 | -$149 |
| $55 (+15%) | -$121 | -$123 | -$126 | -$134 | -$146 | -$149 |
| $57 (+20%) | -$136 | -$137 | -$139 | -$144 | -$149 | -$149 |
Uses GSK's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.